• Source: Scopus
20002021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

The overall goal of our research is to understand why 96% of human prostate adenocarcinomas lose ARF expression even though they are actively proliferating. We hypothesize that loss of ARF leads to deregulated protein synthesis which helps to drive prostate tumorigenesis through a selective mRNA translational program. To test these hypotheses, we are using mouse modeling and in vitro cell culture studies. Because Arf-null mice die by nine months of age from sarcomas and lymphomas before prostate disease can fully develop, we are developing 2 prostate specific knockout models for prostate tumorigenesis: Pb-Cre/Arf-flox and Pb-Cre/Arf-flox/p53-flox. Also, we are using siRNAs directed against p14ARF in primary human prostate epithelial cells to assess the effects of ARF loss on ribosome biogenesis and cell growth and proliferation. Furthering our understanding of the molecular events behind prostate tumorigenesis will help guide identification and therapeutic strategies.

Fingerprint

Dive into the research topics where Len Maggi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.